2-[(4-butylbenzoyl)amino]-N-(3-morpholin-4-ylpropyl)imidazo[1,2-a]pyridine-3-carboxamide
C26H33N5O3 — CID 155562920
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[(4-butylbenzoyl)amino]-N-(3-morpholin-4-ylpropyl)imidazo[1,2-a]pyridine-3-carboxamide
2-[(4-butylbenzoyl)amino]-N-(3-morpholin-4-ylpropyl)imidazo[1,2-a]pyridine-3-carboxamide (PubChem CID 155562920) has the molecular formula C26H33N5O3 and a molecular weight of 463.58 g/mol. Its IUPAC name is 2-[(4-butylbenzoyl)amino]-N-(3-morpholin-4-ylpropyl)imidazo[1,2-a]pyridine-3-carboxamide.
Molecular Properties
| Compound Name | 2-[(4-butylbenzoyl)amino]-N-(3-morpholin-4-ylpropyl)imidazo[1,2-a]pyridine-3-carboxamide |
|---|---|
| PubChem CID | 155562920 |
| Molecular Formula | C26H33N5O3 |
| Molecular Weight | 463.58 g/mol |
| Exact Mass | 463.26 |
| IUPAC Name | 2-[(4-butylbenzoyl)amino]-N-(3-morpholin-4-ylpropyl)imidazo[1,2-a]pyridine-3-carboxamide |
| SMILES | CCCCc1ccc(C(=O)Nc2nc3ccccn3c2C(=O)NCCCN2CCOCC2)cc1 |
| InChI | InChI=1S/C26H33N5O3/c1-2-3-7-20-9-11-21(12-10-20)25(32)29-24-23(31-15-5-4-8-22(31)28-24)26(33)27-13-6-14-30-16-18-34-19-17-30/h4-5,8-12,15H,2-3,6-7,13-14,16-19H2,1H3,(H,27,33)(H,29,32) |
| InChIKey | GEIOLLJVZPVESR-UHFFFAOYSA-N |
| XLogP | 3.38 |
| TPSA | 87.97 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 463.58 |
| LogP ≤ 5 | 3.38 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155562920 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.